ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 168 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $69,000 | -44.8% | 609 | -32.7% | 0.00% | -50.0% |
Q4 2020 | $125,000 | -1.6% | 905 | -41.3% | 0.00% | -33.3% |
Q3 2020 | $127,000 | -42.8% | 1,543 | -47.0% | 0.00% | -62.5% |
Q3 2018 | $222,000 | +335.3% | 2,910 | +164.5% | 0.01% | +100.0% |
Q4 2017 | $51,000 | -75.8% | 1,100 | -67.7% | 0.00% | -81.0% |
Q2 2017 | $211,000 | +2.4% | 3,402 | +12.0% | 0.02% | -16.0% |
Q1 2017 | $206,000 | +18.4% | 3,037 | +22.6% | 0.02% | 0.0% |
Q4 2016 | $174,000 | +9.4% | 2,477 | +10.7% | 0.02% | +4.2% |
Q3 2016 | $159,000 | +59.0% | 2,237 | +9.4% | 0.02% | +50.0% |
Q2 2016 | $100,000 | – | 2,045 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |